生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
|
75789
|
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.
|
Cancer Discov |
2016-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
A549
|
72697
|
Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
|
Biomolecules |
2021-12-9 |
Pubmed
Full text
|
ヒト・動物細胞
|
WI-38(RCB0704)
|
71760
|
DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.
|
Oncol Rep |
2008-11-1 |
Pubmed
|
ヒト・動物細胞
|
A549
,
Lu-134-A(RCB0466)
,
Lu-135(RCB0468)
|
69245
|
Glycoproteomics approach for identifying Glycobiomarker candidate molecules for tissue type classification of non-small cell lung carcinoma.
|
J Proteome Res |
2014-11-7 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
68853
|
A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.
|
PLoS One |
2017-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
68847
|
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.
|
Oncol Rep |
2007-2-1 |
Pubmed
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
68836
|
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
|
Cancer Biol Ther |
2012-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
,
RERF-LC-AI(RCB0444)
|
67012
|
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
|
Br J Cancer |
2020-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
66869
|
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
|
Mol Cancer Res |
2019-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Lu99(RCB1900)
,
EBC-1(RCB1965)
,
LC-2/ad(RCB0440)
|
65061
|
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
|
Mol Cancer Res |
2017-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
,
LC-2/ad(RCB0440)
|
64211
|
Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
|
Mol Cancer Ther |
2014-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
B901L(RCB3530)
|
61797
|
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
|
Sci Rep |
2017-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
A549(RCB0098)
|
59845
|
CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
|
Oncogene |
2019-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
,
II-18(RCB2093)
,
A431(RCB1872)
|
59712
|
Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression.
|
Mol Cancer Ther |
2019-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
58658
|
miR‑20b promotes growth of non‑small cell lung cancer through a positive feedback loop of the Wnt/β‑catenin signaling pathway.
|
Int J Oncol |
2020-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
54086
|
FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
|
J Exp Clin Cancer Res |
2018-9-6 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
52640
|
Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
|
Carcinogenesis |
2018-5-3 |
Pubmed
Full text
|
遺伝子材料
|
pLenti6-PSMA6 (RDB15486)
|
49633
|
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
|
Cancer Sci |
2017-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
LC-2/ad(RCB0440)
,
A549(RCB0098)
,
SP2/0-Ag14(RCB0209)
|
45446
|
Prognostic significance of MYH9 expression in resected non-small cell lung cancer.
|
PLoS One |
2015-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
LC-2/ad(RCB0440)
|
45188
|
A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis.
|
Oncol Rep |
2014-10-1 |
Pubmed
Full text
|